SMG SCOTTS MIRACLE-GRO CO
Agricultural Chemicals · NYSE · SEC CIK 825542 · Fiscal year ends 09/30
Financial factors as of 2026-06-27 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.3%
TTM net income YoY—
TTM EPS YoY48.8%
Revenue 3-yr CAGR-2.8%
Net income 3-yr CAGR—
Margins
Gross margin32.3%
Operating margin11.8%
Net margin2.2%
FCF margin7.8%
EBITDA margin13.7%
Returns
ROE—
ROA2.4%
ROIC (approx.)12.5%
Asset turnover1.08x
Leverage & solvency
Liabilities / assets106.6%
Debt / equity—
Current ratio1.21x
Interest coverage3.53x
Cash quality & payout
Operating cash flow / net income5.00x
Accruals ratio-9.4%
Payout ratio208.9%
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 | FY20222022-09-30 | FY20212021-09-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.41B | $3.55B | $3.55B | $3.92B | $4.92B |
| Cost of revenue | $2.35B | $2.62B | $2.71B | $2.89B | $3.43B |
| Gross profit | $1.04B | $850.50M | $657.30M | $872.90M | $1.47B |
| R&D expense | $34.80M | $34.60M | $35.70M | $45.30M | $45.40M |
| SG&A expense | $603.40M | $559.00M | $551.30M | $613.00M | $743.50M |
| Operating income | $358.60M | $208.80M | -$174.40M | -$434.00M | $723.00M |
| Interest expense | $128.80M | $158.80M | $178.10M | $118.10M | $78.90M |
| Pretax income | $221.70M | -$23.60M | -$453.30M | -$558.10M | $677.10M |
| Income tax | $76.50M | $11.30M | -$73.20M | -$120.60M | $159.80M |
| Net income | $145.20M | -$34.90M | -$380.10M | -$437.50M | $512.50M |
| EBITDA | $421.30M | $273.70M | -$107.10M | -$328.80M | $816.80M |
| EPS (basic) | 2.52 | -0.61 | -6.79 | -7.88 | 9.20 |
| EPS (diluted) | 2.47 | -0.61 | -6.79 | -7.88 | 8.96 |
| Dividends declared per share | 2.64 | 2.64 | 2.64 | 2.64 | 2.52 |
| Weighted avg. shares (diluted) | 58.70M | 56.80M | 56.00M | 55.50M | 57.20M |
| Balance sheet | |||||
| Cash & equivalents | $32.80M | $71.60M | $31.90M | $86.80M | $244.10M |
| Receivables | $160.80M | $176.80M | $304.20M | $299.00M | $483.40M |
| Inventory | $542.70M | $587.50M | $880.30M | $1.34B | $1.13B |
| Current assets | $940.30M | $980.40M | $1.40B | $1.98B | $2.02B |
| PP&E, net | $607.60M | $609.50M | $610.30M | $606.00M | $622.20M |
| Goodwill | $243.90M | $243.90M | $243.90M | $254.00M | $605.20M |
| Intangibles | $352.00M | $418.80M | $436.70M | $580.20M | $709.60M |
| Total assets | $2.74B | $2.87B | $3.41B | $4.30B | $4.80B |
| Current liabilities | $739.70M | $750.30M | $773.70M | $963.90M | $1.14B |
| Short-term debt | $57.20M | $52.60M | $52.30M | $144.30M | $57.80M |
| Long-term debt | $2.05B | $2.17B | $2.56B | $2.83B | $2.24B |
| Total debt | $2.11B | $2.23B | $2.61B | $2.97B | $2.29B |
| Total liabilities | $3.10B | $3.26B | $3.68B | $4.15B | $3.79B |
| Shareholders' equity | -$357.50M | -$390.60M | -$267.30M | $147.70M | $1.01B |
| Net debt | $2.07B | $2.16B | $2.58B | $2.88B | $2.05B |
| Shares outstanding | 57.80M | 57.10M | 56.50M | 55.50M | 55.60M |
| Cash flow statement | |||||
| Operating cash flow | $371.30M | $667.50M | $531.00M | -$129.00M | $271.50M |
| Capital expenditure | $97.40M | $84.00M | $92.80M | $113.50M | $106.90M |
| Free cash flow | $273.90M | $583.50M | $438.20M | -$242.50M | $164.60M |
| Investing cash flow | -$112.10M | -$100.40M | -$65.70M | -$283.20M | -$538.60M |
| Financing cash flow | -$294.00M | -$527.90M | -$520.10M | $255.30M | $494.00M |
| Depreciation & amortization | $62.70M | $64.90M | $67.30M | $105.20M | $93.80M |
| Stock-based compensation | $69.00M | $80.40M | $68.90M | $34.30M | $40.60M |
| Dividends paid | $154.30M | $151.30M | $149.10M | $166.20M | $143.00M |
| Share buybacks | $18.40M | $5.10M | $9.30M | $257.90M | $129.30M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.